Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Int J Clin Oncol

Search In Journal Title:

Abbravation: International Journal of Clinical Oncology

Search In Journal Abbravation:

Publisher

Springer Japan

Search In Publisher:

DOI

10.1007/s00401-012-0976-6

Search In DOI:

ISSN

1437-7772

Search In ISSN:
Search In Title Of Papers:

Alphafetoprotein AFPproducing ovarian tumor in

Authors: Seiji Isonishi Asako Ogura Takako Kiyokawa Michiko Suzuki Shiro Kunito Masanori Hirama Toshiaki Tachibana Kazuhiko Ochiai Tadao Tanaka
Publish Date: 2009/02/20
Volume: 14, Issue: 1, Pages: 70-73
PDF Link

Abstract

Apart from typical yolk sac tumors ovarian tumors with elevated alfafetoprotein AFP are uncommon and the differential diagnosis needs to consider the hepatoid pattern of a yolk sac tumor hepatocellular carcinoma metastatic to the ovary hepatoid carcinoma and other epithelial ovarian tumors We report here an AFPproducing ovarian tumor with uncertain pathological diagnosis which was extremely responsive to chemotherapy A 59yearold Japanese woman presented with lower abdominal distension and was found to have a left ovarian mass on pelvic examination and magnetic resonance imaging MRI scan Laboratory tests showed serum AFP 73 687 ng/ml carbohydrate antigen 125 CA125 1599 U/ml and carcinoembryonic antigen CEA 139 ng/ml Total hysterectomy with bilateral salpingooophorectomy partial omentectomy and low anterior resection of the rectum was performed without any residual macroscopic tumor Microscopically the tumor was characterized by a hepatoid carcinomatous component composed of solid sheets of large eosinophilic cells with pleomorphic nuclei The pathological stage was pT2N0M0 Tumor cells were diffusely immunoreactive for AFP and cytokeratin CAM52 but monoclonal CEA and CA199 were focally positive in the cytoplasm while CA125 was negative The patient was treated postoperatively with three cycles of chemotherapy consisting of bleomycin etoposide and cisplatin with this regimen serum AFP decreased to 16 ng/ml from 12 600 ng/ml just before the initiation of chemotherapy The patient received secondary cytoreductive surgery of systemic lymphadenectomy which revealed no evidence of residual tumor


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Serum total oxidant/antioxidant status and trace element levels in breast cancer patients
  2. Spectrum of cancer risk among Taiwanese with chronic obstructive pulmonary disease
  3. Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials
  4. Estimation of Physiologic Ability and Surgical Stress (E-PASS) versus modified E-PASS for prediction of postoperative complications in elderly patients who undergo gastrectomy for gastric cancer
  5. A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer
  6. Clinicopathologic characteristics and survival of male breast cancer
  7. Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: a case study
  8. Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701)
  9. Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with salvage surgery after concurrent chemoradiotherapy
  10. First case of vaginal radical trachelectomy in a pregnant Japanese woman
  11. Transoral robotic surgery in management of oropharyngeal cancers: a preliminary experience at a tertiary cancer centre in India
  12. Japanese structure survey of radiation oncology in 2009 with special reference to designated cancer care hospitals
  13. Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
  14. Lymphatic invasion identified with D2-40 immunostaining as a risk factor of nodal metastasis in T1 colorectal cancer
  15. A phase II study of lapatinib for brain metastases in patients with HER2-overexpressing breast cancer following trastuzumab based systemic therapy and cranial radiotherapy: subset analysis of Japanese patients
  16. Treatment modalities for Māori and New Zealand European men with localised prostate cancer
  17. Phase II study of first-line chemotherapy with uracil-tegafur plus oral leucovorin in elderly (≥75 years) Japanese patients with metastatic colorectal cancer: SGOSG-CR0501 study
  18. Direct biliopancreatoduodenal invasion by hepatocellular carcinoma: report of the first resected case and review of the literature
  19. Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer
  20. The role of chemotherapy in the treatment of patients with brain metastases from solid tumors
  21. Perceptions and attitudes of Japanese gynecologic cancer patients to Kampo (Japanese herbal) medicines
  22. Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c-T2N0M0 prostate cancer
  23. Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor
  24. Bilateral adrenal leiomyosarcoma treated with multiple local therapies
  25. Mothers’ attitudes in Japan regarding cervical cancer screening correlates with intention to recommend cervical cancer screening for daughters

Search Result: